Mostrando 3 resultados de: 3
Filtros aplicados
Origen
google(3)
Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
ArticleAbstract: Background: Virotherapy represents a promising approach for ovarian cancer. In this regard, conditioPalabras claves:Adenovirus, Anti-tumor immunization, CRAd, ID8, Ovarian Cancer, VirotherapyAutores:Ashshi A.M., Curiel D.T., Dmitriev I.P., El-Shemi A.G., Goedegebuure S.P., Kashentseva E.A., Lu Z.H., Podhajcer O.L., REBECA GONZALEZ-PASTORFuentes:googlescopusAdvanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
ArticleAbstract: For the developing field of gene therapy the successful address of the basic requirement effective gPalabras claves:Adenoviral vectors (Ad), Camelid single domain antibody (sdAb), CD276 [B7-H3], Gene delivery, Human epithelial ovarian cancer cell (SKOV3.ip1), Ovarian Cancer (OvCa) xenograft mouse modelAutores:Curiel D.T., Dmitriev I.P., Kashentseva E.A., Lee M., Lu Z.H., REBECA GONZALEZ-PASTOR, Seaman S., Shoemaker C.B., St. Croix B., Tremblay J.M.Fuentes:googlescopusUnderstanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
ReviewAbstract: Ovarian cancer is the leading cause of death among women with gynecological cancer, with an overallPalabras claves:Autores:Curiel D.T., Goedegebuure S.P., REBECA GONZALEZ-PASTORFuentes:googlescopus